NDC 63629-1069-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-1069
- Requested NDC
- 63629-1069-01
- Package NDCs from labels
- 63629-1069-1, 63629-1069-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-1069-1 | Spironolactone and Hydrochlorothiazide | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-1069 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 1 package rows | 20240602_905568ae-ce27-4978-90c7-b5c93279ecd1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-1069-1 | EA - Each | 63629-1069 | 6255dfc0-9893-430f-836d-b3fb04dc2dab | 1 | 2020-07-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Spironolactone | SPIRONOLACTONE | A-S Medication Solutions | 791251af-d276-40fc-8c35-9d179b20e219 | 2023-02-06 | Warnings, Adverse reactions | 27O7W4T232 |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1ef2a2c-7b8d-4127-8f47-29e430fba70b | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 54224596-325d-473e-adb5-1c86857aba34 | 2023-02-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c1052d38-fd75-40c2-a685-0e889009be0b | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 84dba61d-cae2-4f21-9a9e-3088f356f838 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c4fe84e3-c291-4220-95c1-a2bd02b1e134 | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 34703033-14c4-459c-8b8f-2f2e1145aff7 | 2023-01-30 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 9492a1cd-c012-4b43-931d-235220065e1e | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 3b80f726-9e1e-4d44-ad4f-afd10e26292f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Silicea | SILICON DIOXIDE | Boiron | 86d2db09-9c46-37f7-e053-2a91aa0a326f | 2023-01-23 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3be33-b50e-e649-e053-2a91aa0acfc5 | 2023-01-23 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3be33-b4fb-e649-e053-2a91aa0acfc5 | 2023-01-23 | ETJ7Z6XBU4 | |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 8c65d555-8db8-40d9-be30-309ef09f19be | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 538ea34a-1ac3-48c8-b841-43be09285e12 | 2023-01-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS | ab40b62b-9f8d-4394-92d5-09d9f1941eaa | 2023-01-16 | Warnings, Adverse reactions | OJ245FE5EU |
| Gyno Complex | VIBURNUM OPULUS, MAGNESIA PHOSPHORICA, FOLLICULINUM, PULSATILLA (PRATENSIS), BORAX, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, SILICEA, THUJA OCCIDENTALIS | Deseret Biologicals, Inc | dfaaa56a-4226-4f62-a219-d3f89fe7afe3 | 2023-01-12 | Warnings | ETJ7Z6XBU4 |
| Silicea | SILICON DIOXIDE | Boiron | 86d367e5-e846-54ba-e053-2991aa0a63d4 | 2023-01-12 | ETJ7Z6XBU4 | |
| Perfect Sleep | ADENOSINUM TRIPHOSPHORICUM DINATRUM, PANTOTHENIC ACID, UBIDECARENONUM, PINEAL GLAND (SUIS), SARCOLACTICUM ACIDUM, MELATONIN, PYRROLE, TRYPTOPHAN, ARSENICUM ALBUM, AVENA SATIVA, CHAMOMILLA, COFFEA CRUDA, MERCURIUS CORROSIVUS, PASSIFLORA INCARNATA, SILICEA, ZINCUM VALERIANICUM, DYSENTERY BACILLUS, GAERTNER BACILLUS | Deseret Biologicals, Inc. | f267fff4-f331-49b8-bd48-7d383da52246 | 2023-01-11 | Warnings | ETJ7Z6XBU4 |
| DALEKTRO N | SILVER NITRATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, COBALTOUS NITRATE HEXAHYDRATE, CUPRIC ACETATE, IRON, POTASSIUM CARBONATE, MAGNESIUM CHLORIDE, MANGANESE ACETATE TETRAHYDRATE, SELENIUM, SILICON DIOXIDE, AND ZINC PHOSPHIDE | PEKANA Natruheilmittel GmbH | 2b39ce30-54ff-4586-bda1-d9410140b26e | 2023-01-11 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.